metoclopramide has been researched along with Bone Neoplasms in 1 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Bone Neoplasms: Tumors or cancer located in bone tissue or specific BONES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In children and adolescents with osteosarcoma, granisetron was safe and more efficient than metoclopramide plus dimenhydrinate for controlling chemotherapy-induced emesis and nausea." | 5.12 | Contribution to the treatment of nausea and emesis induced by chemotherapy in children and adolescents with osteosarcoma. ( Caran, EM; Luisi, FA; Petrilli, AS; Tanaka, C, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Luisi, FA | 1 |
| Petrilli, AS | 1 |
| Tanaka, C | 1 |
| Caran, EM | 1 |
1 trial available for metoclopramide and Bone Neoplasms
| Article | Year |
|---|---|
Contribution to the treatment of nausea and emesis induced by chemotherapy in children and adolescents with osteosarcoma.
Topics: Adolescent; Antiemetics; Antineoplastic Agents; Bone Neoplasms; Child; Dimenhydrinate; Female; Grani | 2006 |